About

Publications While At HealthPartners

selected publications

Journal Article

Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6). 

Lancet (London, England). 2009

Contact

full name

member of the LEAD-6 Study Group

Quick Info

 

Collaboration

Co-author network

Map of science